rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
1
|
pubmed:dateCreated |
2004-2-26
|
pubmed:abstractText |
Islet transplantation is limited by islet graft failure because of poor revascularization, host immune rejection, and nonspecific inflammatory response. Human vascular endothelial growth factor (hVEGF) gene delivery is likely to promote islet revascularization and survival.
|
pubmed:grant |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
0724-8741
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
21
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
15-25
|
pubmed:dateRevised |
2007-11-14
|
pubmed:meshHeading |
pubmed-meshheading:14984253-Animals,
pubmed-meshheading:14984253-Cells, Cultured,
pubmed-meshheading:14984253-Drug Delivery Systems,
pubmed-meshheading:14984253-Gene Therapy,
pubmed-meshheading:14984253-Genetic Vectors,
pubmed-meshheading:14984253-Humans,
pubmed-meshheading:14984253-Islets of Langerhans,
pubmed-meshheading:14984253-Islets of Langerhans Transplantation,
pubmed-meshheading:14984253-Jurkat Cells,
pubmed-meshheading:14984253-Kidney Cortex,
pubmed-meshheading:14984253-Male,
pubmed-meshheading:14984253-Mice,
pubmed-meshheading:14984253-Mice, Inbred NOD,
pubmed-meshheading:14984253-Mice, SCID,
pubmed-meshheading:14984253-Neovascularization, Physiologic,
pubmed-meshheading:14984253-Rats,
pubmed-meshheading:14984253-Transfection,
pubmed-meshheading:14984253-Vascular Endothelial Growth Factor A
|
pubmed:year |
2004
|
pubmed:articleTitle |
Vascular endothelial growth factor gene delivery for revascularization in transplanted human islets.
|
pubmed:affiliation |
Department of Pharmaceutical Sciences, University of Tennessee Health Science Center, 26 South Dunlap Street, Feurt Building RM 406, Memphis, Tennessee 38163, USA.
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, U.S. Gov't, P.H.S.,
Research Support, Non-U.S. Gov't
|